Licensing leverage Hairpin Technologies acts as the exclusive licensing agent for CSHL’s shRNA technology, presenting a clear sales angle to biotech manufacturers, distributors, and end-users seeking to license or integrate shRNA tools.

ShRNA emphasis With a focus on short hairpin RNA and its use in research and drug discovery, target potential customers include gene therapy researchers, biotech tool suppliers, and contract research organizations looking to enhance their RNAi portfolios.

Patent-backed A robust U.S. and international patent portfolio underpins licensing discussions, enabling sales conversations around freedom-to-operate assurances, royalty opportunities, and risk mitigation for potential licensees.

Strategic outreach Hairpin Technologies concentrates on marketing, corporate outreach, and out-licensing efforts, signaling readiness to partner with distributors and manufacturers to accelerate market reach of shRNA assets.

Growth opportunities Given a lean operation and low revenue, there is potential to scale through channel partnerships, strategic collaborations with large CROs or biotech suppliers, and expansion into adjacent RNA-based research tools.